Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers SNDL
420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Kaplan Fox &amp; Kilsheimer LLP is Investigating Applied Therapeutics, Inc. (APLT) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
Breaking Free from Recurrent C. diff, a Serious Gut Infection
Via Brandpoint
Topics Product Recall
Exposures Legal Product Safety
Southbridge, MA Veteran & Author Publishes Memoir
Via PR Leap
Topics Product Recall
Exposures Legal Product Safety
Why This Cannabis Company Recalled Over 3,000 Gummies In Missouri
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
'Never Thought I'd Be A Person To Have a Nervous Breakdown' – Elon Musk Recalls Christmas Of 2008 'Everything Was Going Wrong At Once'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands Leadership Team to Support TNX-102 SL Launch
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
New Crime Novel Explores Tragedy, Mystery, And Resilience Against All Odds
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
Via Benzinga
Exposures Product Safety
Tickers BTI MO TPB
Actuated Medical Secures FDA 510(k) Clearance for GripTract-GI™ Endoscopic Tissue Manipulator, a Major Advancement in GI Procedural Innovation
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NVIDIA Invested in These 2 AI Stocks, Should You?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers EXAI MGA NVDA OUST
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
Via Newsfile
Exposures Product Safety
Tickers ELTP
FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
Via Benzinga
Exposures Product Safety
Tickers BLUE
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
Via Benzinga
Exposures Product Safety
Tickers APLT
Orthopedic Surgeon Dr. Robert MacArthur Opens Up On His Early Career and Education in New Online Interview
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Tickers AZN HIMS LLY PFE
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Via Benzinga
Exposures Product Safety
Tickers CABA
2 Generic Drug Stocks Ready to Surge in 2025
Via MarketBeat
Topics Government Intellectual Property
Exposures Intellectual Property Political Product Safety
Tickers AMGN LXRX PFE TEVA
Bird Flu Found In Raw Milk Leads To Recall In California
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GSK MRNA SNY
Why Hims & Hers Stock Jumped on Massive FDA News
Via The Motley Fool
Exposures Product Safety
Tickers HIMS
InvestorkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) COO to Present at NobleCon20 Emerging Growth Conference
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers CNSP
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Via Benzinga
Exposures Product Safety
Tickers BAYRY BBIO PFE
HUMA DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before January 17, 2025
Via TheNewswire.com
Exposures Product Safety
HUMACYTE DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on January 17, 2025
Via TheNewswire.com
Exposures Product Safety
AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
Via Benzinga
Exposures Product Safety
Tickers AZN
HUMA Deadline to Lead in Securities Fraud Lawsuit is January 17, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Via Benzinga
Exposures Product Safety
Tickers JAZZ ZYME
Nikola Recalls Dozens of its Trucks as Defective Display Raises Possibility of Crashes
Via Investor Brand Network
Topics Electric Vehicles Product Recall
Exposures Electric Vehicles Legal Product Safety
Tickers NKLA
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.